ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Short-Term Debt : kr0.29 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Short-Term Debt?

ExpreS2ion Biotech Holding AB's Short-Term Debt for the quarter that ended in Mar. 2024 was kr0.29 Mil.

ExpreS2ion Biotech Holding AB's quarterly Short-Term Debt declined from Sep. 2023 (kr2.09 Mil) to Dec. 2023 (kr0.28 Mil) but then increased from Dec. 2023 (kr0.28 Mil) to Mar. 2024 (kr0.29 Mil).

ExpreS2ion Biotech Holding AB's annual Short-Term Debt declined from Dec. 2021 (kr1.92 Mil) to Dec. 2022 (kr1.76 Mil) and declined from Dec. 2022 (kr1.76 Mil) to Dec. 2023 (kr0.28 Mil).

ExpreS2ion Biotech Holding AB Short-Term Debt Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Short-Term Debt Chart

ExpreS2ion Biotech Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

1.49

1.89

1.92

1.76

0.28

ExpreS2ion Biotech Holding AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															2.01	2.12	2.09	0.28	0.29

ExpreS2ion Biotech Holding AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

ExpreS2ion Biotech Holding AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

5JD:Germany

Address

c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25

Website

https://www.expres2ionbio.com

ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines